4.7 Review

The volume-outcome relation in the surgical treatment of esophageal cancer

Journal

CANCER
Volume 118, Issue 7, Pages 1754-1763

Publisher

WILEY
DOI: 10.1002/cncr.26383

Keywords

hospital volume; treatment outcome; esophageal neoplasms; esophagectomy; mortality; quality assurance; hospital mortality

Categories

Ask authors/readers for more resources

This study was undertaken to conduct a systematic review and meta-analysis of the literature on the relation between procedural volume and outcome of esophagectomies. A systematic search was carried out to identify articles investigating effects of hospital or surgeon volume on short-term and long-term outcomes published between 1995 and 2010. Articles were scrutinized for methodological quality, and after inclusion of only high-quality studies, a meta-analysis assuming a random effects model was done to estimate the effect of higher volume on patient outcome. Heterogeneity in study results was evaluated with an I2-test and risk of publication bias with an Egger regression intercept. Forty-three studies were found. Sixteen studies met the strict inclusion criteria for the meta-analysis on hospital volume and postoperative mortality and 4 studies on hospital volume and survival. The pooled estimated effect size was significant for high-volume providers in the analysis of postoperative mortality (odds ratio [OR], 2.30; 95% confidence interval [CI], 1.89-2.80) and in the survival analysis (OR, 1.17; 95% CI, 1.05-1.30). The meta-analysis of surgical volume and outcome showed no significant results. Studies in which the results were adjusted not only for patient characteristics but also for tumor characteristics and urgency of the operation showed a stronger correlation between hospital volume and mortality. Also, studies performed on data from the United States showed higher effect sizes. The evidence for hospital volume as an important determinant of outcome in esophageal cancer surgery is strong. Concentration of procedures in high-volume hospitals with a dedicated setting for the treatment of esophageal cancer might lead to an overall improvement in patient outcome. Cancer 2012;. (C) 2011 American Cancer Society.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Cardiac & Cardiovascular Systems

Textbook outcome as a composite outcome measure in non-small-cell lung cancer surgery

Martijn G. ten Berge, Naomi Beck, Willem Hans Steup, Ad F. T. M. Verhagen, Thomas J. van Brakel, Wilhelmina H. Schreurs, Michel W. J. M. Wouters

Summary: The study aimed to develop a new composite measure 'textbook outcome' to evaluate and improve quality of surgical care for NSCLC patients. Results showed that 26.4% of patients achieved textbook outcome, with insufficient lymph node dissection being the most substantial factor affecting it.

EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2021)

Article Oncology

T-VEC for stage IIIB-IVM1a melanoma achieves high rates of complete and durable responses and is associated with tumor load: a clinical prediction model

Emma H. A. Stahlie, Viola Franke, Charlotte L. Zuur, Willem M. C. Klop, Bernies van der Hiel, Bart A. van de Wiel, Michel W. J. M. Wouters, Yvonne M. Schrage, Winan J. van Houdt, Alexander C. J. van Akkooi

Summary: The study demonstrates that intralesional T-VEC monotherapy can achieve high complete and durable responses. The prediction model suggests that using T-VEC in patients with less tumor burden is associated with better outcomes, indicating the potential benefit of earlier intervention in the disease course.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)

Article Cardiac & Cardiovascular Systems

Variation in incidence, prevention and treatment of persistent air leak after lung cancer surgery

Fieke Hoeijmakers, Koen J. Hartemink, Ad F. Verhagen, Willem H. Steup, Elske Marra, W. F. Boudewijn Roell, David J. Heineman, Wilhelmina H. Schreurs, Rob A. E. M. Tollenaar, Michel W. J. M. Wouters

Summary: In the Netherlands, there is wide variation in the incidence and perioperative (preventive) management of PAL. Using water seal instead of suction drainage and increasing awareness are potential measures to reduce this variation.

EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2022)

Article Oncology

Conventional regression analysis and machine learning in prediction of anastomotic leakage and pulmonary complications after esophagogastric cancer surgery

Robert T. van Kooten, Renu R. Bahadoer, Bouwdewijn ter Buurkes de Vries, Michel W. J. M. Wouters, Rob A. E. M. Tollenaar, Henk H. Hartgrink, Hein Putter, Johan L. Dikken

Summary: This study investigates the added value of machine learning to linear regression in predicting complications after upper gastrointestinal cancer surgery. The results show that while machine learning can predict complications, it does not outperform linear regression.

JOURNAL OF SURGICAL ONCOLOGY (2022)

Article Oncology

A preoperative prediction model for anastomotic leakage after rectal

V. T. Hoek, S. Buettner, C. L. Sparreboom, R. Detering, A. G. Menon, G. J. Kleinrensink, M. W. J. M. Wouters, J. F. Lange, J. K. Wiggers

Summary: This study aimed to develop a robust preoperative prediction model for anastomotic leakage after surgical resection for rectal cancer. Significant risk factors were identified and included in the prediction model, which can be used for patient counselling and risk-stratification before undergoing rectal resection for cancer.
Article Health Care Sciences & Services

Medication Use and Clinical Outcomes by the Dutch Institute for Clinical Auditing Medicines Program: Quantitative Analysis

Rawa Kamaran Ismail, Jesper van Breeschoten, Silvia van der Flier, Caspar van Loosen, Anna Maria Gerdina Pasmooij, Maaike van Dartel, Alfons van den Eertwegh, Anthonius de Boer, Michel Wouters, Doranne Hilarius

Summary: The Dutch Institute for Clinical Auditing's Medicines Program evaluates the real-world effectiveness of expensive medicines using existing data sources. This study demonstrates the potential of adding declaration data to quality registries to provide benchmark information for participating centers. By linking national registries to clinical and financial data, as well as survival data, detailed insights into medication use, treatment information, clinical outcomes, and costs are obtained.

JOURNAL OF MEDICAL INTERNET RESEARCH (2022)

Article Oncology

End-of-Life Use of Systemic Therapy in Patients With Advanced Melanoma: A Nationwide Cohort Study

Jesper van Breeschoten, Rawa K. Ismail, Michel W. J. M. Wouters, Doranne L. Hilarius, Liesbeth C. de Wreede, John B. Haanen, Christian U. Blank, Maureen J. B. Aarts, Franchette W. P. J. van den Berkmortel, Jan Willem B. de Groot, Geke A. P. Hospers, Ellen Kapiteijn, Djura Piersma, Rozemarijn S. van Rijn, Marion A. Stevense-den Boer, Astrid A. M. van der Veldt, Gerard Vreugdenhil, Marye J. Boers-Sonderen, Karijn P. M. Suijkerbuijk, Alfons J. M. van den Eertwegh

Summary: The minority of Dutch patients with metastatic melanoma started a new systemic therapy in the last phase of life. However, the percentages varied between Dutch melanoma centers. Financial impact of these therapies in the last phase of life is relatively small.

JCO ONCOLOGY PRACTICE (2022)

Article Oncology

Patterns of care over 10 years in young breast cancer patients in the Netherlands, a nationwide population-based study

Nansi Maliko, Nina Bijker, Monique E. M. M. Bos, Michel W. J. M. Wouters, Marie-Jeanne T. F. D. Vrancken Peeters

Summary: This study compares the patient and treatment characteristics of young and older breast cancer patients and analyzes the outcome of quality indicators over time. The results show that young patients often have unfavorable tumors, but treatment procedures are performed with higher adherence to quality indicators. Both young and older patients benefit from some treatment de-escalation trends.

BREAST (2022)

Article Oncology

Baseline ultrasound and FDG-PET/CT imaging in Merkel cell carcinoma

Lisanne P. Zijlker, Max Bakker, Bernies van Der Hiel, Annemarie Bruining, W. Martin C. Klop, Charlotte L. Zuur, Michel W. J. M. Wouters, Alexander C. J. van Akkooi

Summary: This study aimed to determine the value of baseline ultrasound (US) and (18)fluorodeoxyglucose-positron emission tomography/computed tomography ((18)FDG-PET/CT) imaging in MCC patients. The results showed that baseline imaging frequently upstaged Stage I/II MCC patients to Stage III, both by US and FDG-PET/CT, while Stage IV disease was rarely identified. Patients who presented with palpable nodes were frequently upstaged to Stage IV by FDG-PET/CT imaging.

JOURNAL OF SURGICAL ONCOLOGY (2023)

Article Oncology

Computed tomography-based preoperative muscle measurements as prognostic factors for anastomotic leakage following oncological sigmoid and rectal resections

Robert T. T. van Kooten, Cor J. J. Ravensbergen, Sophie C. D. van Bueseck, Willem Grootjans, Koen C. M. J. Peeters, Fabian A. A. Holman, Jan W. T. Heemskerk, Michel W. J. M. Wouters, Ana Navas Canete, Rob A. E. M. Tollenaar

Summary: This study found that decreased muscle measurements (PMI and SMI) on preoperative CT scans were associated with increased risk of anastomotic leakage. These results suggest that preoperative CT-based muscle measurements can be used as prognostic factors for risk stratification of anastomotic leakage.

JOURNAL OF SURGICAL ONCOLOGY (2023)

Article Oncology

Systemic Therapy in Advanced Nodular Melanoma versus Superficial Spreading Melanoma: A Nation-Wide Study of the Dutch Melanoma Treatment Registry

Daan Jan Willem Rauwerdink, Remco van Doorn, Jos van der Hage, Alfonsus J. M. Van den Eertwegh, John B. A. G. Haanen, Maureen Aarts, Franchette Berkmortel, Christian U. Blank, Marye J. Boers-Sonderen, Jan Willem B. De Groot, Geke A. P. Hospers, Melissa de Meza, Djura Piersma, Rozemarijn S. Van Rijn, Marion Stevense, Astrid Van der Veldt, Gerard Vreugdenhil, Michel W. J. M. Wouters, Karijn Suijkerbuijk, Monique van der Kooij, Ellen Kapiteijn

Summary: This study aimed to compare the efficacy of immunotherapy and BRAF/MEK inhibitors in metastatic nodular melanoma and metastatic superficial spreading melanoma. The results showed no difference in efficacy between the two treatments for patients with either type of melanoma. However, patients with nodular melanoma had shorter distant metastasis-free survival and worse overall survival, suggesting that the poorer overall survival of nodular melanoma is mainly due to the propensity for metastatic spread after the primary diagnosis.

CANCERS (2022)

Article Oncology

Adjuvant BRAF-MEK Inhibitors versus Anti PD-1 Therapy in Stage III Melanoma: A Propensity-Matched Outcome Analysis

Melissa M. M. De Meza, Willeke A. M. Blokx, Johannes J. J. Bonenkamp, Christian U. U. Blank, Maureen J. B. Aarts, Franchette W. P. J. van den Berkmortel, Marye J. J. Boers-Sonderen, Jan Willem B. De Groot, John B. A. G. Haanen, Geke A. P. Hospers, Ellen Kapiteijn, Olivier J. J. Van Not, Djura Piersma, Rozemarijn S. S. Van Rijn, Marion Stevense-den Boer, Astrid A. M. van der Veldt, Gerard Vreugdenhil, Alfonsus J. M. van den Eertwegh, Karijn P. M. Suijkerbuijk, Michel W. J. M. Wouters

Summary: BRAF/MEK therapy and anti-PD-1 therapy have shown better recurrence-free survival in stage III melanoma patients with BRAF V600 mutations. This study aimed to compare the toxicity and survival outcomes of these therapies in daily practice. The results showed that grade >= 3 toxicity occurred in 11.5% of patients, leading to early treatment discontinuation in 71.1% of cases. At 12 months, patients treated with BRAF/MEK therapy had better progression-free survival than those treated with anti-PD-1 therapy, but this difference was no longer observed at 18 months.

CANCERS (2023)

Article Endocrinology & Metabolism

Use of hospital care among Dutch diabetes patients

Silvia A. G. de Vries, Jessica C. G. Bak, Vincent A. Stangenberger, Michel W. J. M. Wouters, Max Nieuwdorp, Theo C. J. Sas, Carianne L. Verheugt

Summary: The study examined healthcare resource utilization and hospital expenditure of patients with diabetes in Dutch hospitals from 2019 to 2020. The results showed that the hospital resource use of Dutch diabetes patients is high, mainly due to the burden of cardiovascular complications. Therefore, early treatment and prevention of complications are crucial for controlling future healthcare expenditure on diabetes patients.

DIABETES OBESITY & METABOLISM (2023)

Article Oncology

A Survival Tree of Advanced Melanoma Patients with Brain Metastases Treated with Immune Checkpoint Inhibitors

Olivier J. van Not, Thijs T. Wind, Rawa K. Ismail, Arkajyoti Bhattacharya, Mathilde Jalving, Christian U. Blank, Maureen J. B. Aarts, Franchette W. P. J. van den Berkmortel, Marye J. Boers-Sonderen, Alfonsus J. M. van den Eertwegh, Jan Willem B. de Groot, John B. Haanen, Ellen Kapiteijn, Manja Bloem, Djura Piersma, Rozemarijn S. van Rijn, Marion Stevense-den Boer, Astrid A. M. van der Veldt, Gerard Vreugdenhil, Michel W. J. M. Wouters, Willeke A. M. Blokx, Karijn P. M. Suijkerbuijk, Rudolf S. N. Fehrmann, Geke A. P. Hospers

Summary: This study aimed to identify prognostic factors in advanced melanoma patients with brain metastases treated with immune checkpoint inhibitors. The analysis found that the serum lactate dehydrogenase (LDH) level was the strongest clinical parameter associated with survival.

CANCERS (2023)

Review Health Care Sciences & Services

Visualization formats of patient-reported outcome measures in clinical practice: a systematic review about preferences and interpretation accuracy

Elaine A. C. Albers, Itske Fraterman, Iris Walraven, Erica Wilthagen, Sanne B. Schagen, Iris M. van der Ploeg, Michel W. J. M. Wouters, Lonneke V. van de Poll-franse, Kelly M. de Ligt

Summary: Graphic visualization formats for Patient-Reported Outcome Measures (PROMs) data in clinical practice were evaluated in this systematic literature review. The study found no predominant format preference or interpretation accuracy among patients and clinicians. Patients preferred bar charts and line graphs for easy and quick retrieval of PROMs scores over time, while clinicians had similar accuracy and preferences for different graphic visualization formats. The interpretation of PROMs data can be improved by using colors, descriptive labels, and brief definitions.

JOURNAL OF PATIENT-REPORTED OUTCOMES (2022)

No Data Available